U.S. Veterinary Oncology Diagnostics Market Anticipated to Value USD 2,228.87 Million by 2034, CAGR at 8.4%

BySheetal Gajbhiye

U.S. Veterinary Oncology Diagnostics Market Analysis: Opportunities, Innovations, and Growth Potential Through 2034

U.S. Veterinary Oncology Diagnostics Market size and share is currently valued at USD 992.64 billion in 2024 and is anticipated to generate an estimated revenue of USD 2,228.87 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 8.4% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 – 2034

Market Definition:

This market focuses on diagnostic solutions used to detect, monitor, and manage cancer in animals. It includes molecular testing, imaging modalities, and pathology services tailored for veterinary use. These diagnostics assist veterinarians in identifying tumor types, determining malignancy, and guiding treatment decisions for pets and livestock affected by cancer.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:

https://www.polarismarketresearch.com/industry-analysis/us-veterinary-oncology-diagnostics-market/request-for-sample 

Key Report Highlights :

  • The report highlights the key region that accounts for the highest revenue share in the global U.S. Veterinary Oncology Diagnostics Market.
  • It identifies the leading country within this region that makes a significant contribution to the market’s overall performance.
  • The report outlines the dominant segment that holds a major share of the market.
  • It also emphasizes the fastest-growing segment projected to gain strong traction during the forecast period.
  • Qualitative and quantitative market analysis have been used to provide an in-depth understanding of the market.

Market Overview: Key Figures at a Glance:

Report Attributes

Details

Market Size Value in 2024

USD 992.64 billion

Market Size Value in 2025

USD 1,074.04 billion

Revenue Forecast by 2034

USD 2,228.87 billion

CAGR

8.4% from 2025 to 2034

Market Opportunity:

Increased pet ownership, growing awareness of animal health, and advances in veterinary medicine are driving demand for oncology diagnostics. Rising incidences of cancer in pets, coupled with owners’ willingness to invest in high-end care, are opening opportunities for specialized diagnostic labs and veterinary clinics across the U.S.

𝐂𝐥𝐢𝐜𝐤 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:

https://www.polarismarketresearch.com/industry-analysis/us-veterinary-oncology-diagnostics-market 

Market Key Players:

The competitive landscape features a mix of long-standing companies and emerging contenders. Leading players are actively pursuing R&D initiatives and strategic moves to strengthen their market position. Notable participants include:

  • Antech Diagnostics, Inc. (Mars Inc.)
  • CANCAN DIAGNOSTICS
  • Embark Veterinary, Inc
  • Gold Standard Diagnostics (Eurofins Technologies)
  • IDEXX Laboratories, Inc.
  • Neogen Corporation
  • Oncotect
  • PetDx
  • VolitionRx Limited
  • Zoetis

Similar Posts